DePuy to pay medical costs of patients affected by faults

US FIRM DePuy Orthopaedics has promised to cover the costs of any medical treatment needed by patients who received potentially faulty hip implants manufactured by the company, which are the subject of a voluntary global recall.

DePuy, which manufactures a range of artificial hips and knees, said it intends to cover all reasonable and customary costs of monitoring and treating affected patients.

It is estimated that up to 93,000 people worldwide, including 3,500 patients in the Republic, have been implanted with the affected products.